Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Invivyd, Inc. (IVVD) f/k/a Adagio Therapeutics, Inc.

SAN DIEGO--(BUSINESS WIRE)---- $IVVD #ADG20--Invivyd, Inc. (IVVD) misled the public regarding the viability of its lead drug candidate and the drug's impact on the COVID-19 Omicron variant